Premium
TPG Growth, which has backed several traditional Indian healthcare companies ranging from hospitals to medical devices makers, is sitting on over 3x return on its two-year investment in an Indian bulk drugs maker. At the price at which it made the latest part-exit, TPG is sitting on 3.24x returns from Solara ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
